Dr. Xiping Zhang 张喜平
Chief Physician
Department of Breast Surgery, Zhejiang Cancer Hospital, Hangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis, surgery (including mastectomy, reconstruction, and minimally invasive techniques), and comprehensive treatment of benign and malignant breast tumors, hyperplasia, cysts, inflammation, and nipple discharge. Applies traditional Chinese medicine for breast diseases and chemotherapy-induced hand-foot syndrome.
Dr. Zhang holds a doctorate in surgery and has nearly 30 years of clinical experience. Training includes fellowships at Fudan University Shanghai Cancer Center, Tianjin Medical University Cancer Institute, and Hunan Cancer Hospital. Dr. Zhang has published over 80 SCI papers, led more than 10 research projects, and received over 20 provincial and municipal science and technology awards.
Name order: in Chinese the family name comes first (Zhang Xiping). Papers usually list the name as Xiping Zhang or Zhang X.
Selected publications
28 papers on PubMed matched by name and affiliation; 15 as first or senior author since 2016. Most recent first- or senior-author papers:
- Biochim Biophys Acta Mol Basis Dis, 2025 (senior author): MiRNA affects the advancement of breast cancer by modulating the immune system's response. PubMed 40037267
- J Zhejiang Univ Sci B, 2025 (senior author): Erratum to: Advantages of contrast-enhanced ultrasound in the localization and diagnostics of sentinel lymph nodes in breast cancer. PubMed 40082207
- Eur J Med Res, 2025 (senior author): LncRNA-MALAT1 promotes triple-negative breast cancer progression and function as ceRNA to target REEP5 by sponging miR-106a-5p. PubMed 40059235
- J Zhejiang Univ Sci B, 2023 (senior author): Roles of lncRNA in the diagnosis and prognosis of triple-negative breast cancer. PubMed 38057269
- J Zhejiang Univ Sci B, 2023 (senior author): Advantages of contrast-enhanced ultrasound in the localization and diagnostics of sentinel lymph nodes in breast cancer. PubMed 37961801
- Front Mol Biosci, 2023 (senior author): New progress in the role of microRNAs in the diagnosis and prognosis of triple negative breast cancer. PubMed 37122564
- Clin Breast Cancer, 2020 (first author): Research Progress on Long Non-coding RNAs and Drug Resistance of Breast Cancer. PubMed 32414649
- J Zhejiang Univ Sci B, 2020 (senior author): Screening of miRNAs associated with lymph node metastasis in Her-2-positive breast cancer and their relationship with prognosis. PubMed 32478495
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion